GE HealthCare (GEHC)

• Market cap: $36.1B
• 1 day: 1.91%
• 5 days: -2.29%
• 1 month: -7.06%
• 3 months: -12.59%
• 6 months: -0.67%
• Year to date: 3.33%
• 1 year: 4.60%
• 5 years: 31.52%
• 10 years: 31.52%
• Sector: Healthcare
• Industry: X-Ray Apparatus & Tubes & Related Irradiation Apparatus

About: GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).

Employees: 51,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

53% more first-time investments, than exits

New positions opened: 155 | Existing positions closed: 101

25% more funds holding in top 10

Funds holding in top 10: 8 [Q2] → 10 (+2) [Q3]

19% more capital invested

Capital invested by funds: $29.5B [Q2] → $35B (+$5.57B) [Q3]

14% more repeat investments, than reductions

Existing positions increased: 462 | Existing positions reduced: 404

12% more call options, than puts

Call options by funds: $579M | Put options by funds: $518M

5% more funds holding

Funds holding: 1,191 [Q2] → 1,245 (+54) [Q3]

0.89% less ownership

Funds ownership: 82.85% [Q2] → 81.96% (-0.89%) [Q3]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $74 6% downside
• Avg. target: $94 18% upside
• High target: $102 29% upside

4 analyst ratings

• positive: 3 75%
• neutral: 0 0%
• negative: 1 25%

Wells Fargo Larry Biegelsen 51% 1-year accuracy 24 / 47 met price target	22% upside $96	Overweight Maintained	31 Oct 2024
Evercore ISI Group Vijay Kumar 60% 1-year accuracy 28 / 47 met price target	29% upside $102	Outperform Maintained	1 Oct 2024
Stifel Rick Wise 62% 1-year accuracy 18 / 29 met price target	29% upside $102	Buy Maintained	30 Sept 2024
UBS Graham Doyle 50% 1-year accuracy 1 / 2 met price target	6% downside $74	Sell Downgraded	26 Sept 2024